• HOME
  • ABOUT
    • TEAM
  • STRATEGY
  • PORTFOLIO
  • ADDRESS

Pix Vine Capital

PixVC provides early-stage venture capital to startups in the areas of Info-Tech, Med-Tech and Eco-Tech.

  • HOME
  • ABOUT
    • TEAM
  • STRATEGY
  • PORTFOLIO
  • ADDRESS

Singapore develops innovative non-integrating CAR T vector system

April 16, 2021

 

Proteona, a Singapore-based single-cell precision medicine company, has announced the publication of the results of a long-term collaboration with researchers at the German Cancer Research Center (DKFZ) and its National Center for Tumor Diseases (NCT) to develop and characterize an innovative non-integrating CAR T vector system.

More from BioSpectrum Asia 

Filed Under: Uncategorized

© 2025 Pix Vine Capital